Cannabinoids improve driving ability in a Tourette's patient

Psychiatry Research

Volumn 190, Issue 2-3, 2011, Pages 382-

  Brunnauer, Alexander ^a,b   Segmiller, Felix Maximilian ^a   Volkamer, Thomas ^a   Laux, Gerd ^b   Müller, Norbert ^a   Dehning, Sandra ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Inn Salzach Hospital Wasserburg/Inn   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; CANNABINOID; CLONAZEPAM; DOPAMINE RECEPTOR BLOCKING AGENT; DRONABINOL; TETRABENAZINE;

ATTENTION; BRAIN FUNCTION; DRIVING ABILITY; GILLES DE LA TOURETTE SYNDROME; HOSPITAL ADMISSION; HUMAN; INTELLIGENCE QUOTIENT; LETTER; MEMORY; NEUROIMAGING; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SYMPTOMATOLOGY; TENDON REFLEX; TIC; TREATMENT RESPONSE;

ADULT; AUTOMOBILE DRIVING; CANNABINOIDS; HUMANS; MALE; MOTOR SKILLS DISORDERS; PSYCHOMOTOR PERFORMANCE; TOURETTE SYNDROME; VISUAL PERCEPTION;

EID: 82955203477     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2011.05.033     Document Type: Letter

References (1)

1. Muller-Vahl K.R., Prevedel H., Theloe K., Kolbe H., Emrich H.M., Schneider U. Treatment of Tourette syndrome with delta-9-tetrahydrocannabinol (delta 9-THC): no influence on neuropsychological performance. Neuropsychopharmacology 2003, 28(2):384-388. Feb.